Cargando…

Response to “Poor control vaccines in two randomised trials of malaria vaccine?”

Detalles Bibliográficos
Autores principales:	Bejon, Philip, Abdulla, Salim, Lusingu, John, Olotu, Ally, Leach, Amanda, Lievens, Marc, Tanner, Marcel, von Seidlein, Lorenz
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Science 2009
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713779/ https://www.ncbi.nlm.nih.gov/pubmed/19486956 http://dx.doi.org/10.1016/j.vaccine.2009.05.035

Ejemplares similares

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01(E) on Blood Stage Immunity in Young Children
por: Bejon, Philip, et al.
Publicado: (2011)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
por: Bejon, Philip, et al.
Publicado: (2013)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
por: Olotu, Ally, et al.
Publicado: (2011)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
por: White, Michael T, et al.
Publicado: (2014)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
por: Lievens, Marc, et al.
Publicado: (2011)

Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum Parasites
por: Bejon, Philip, et al.
Publicado: (2011)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

FEEDBACK OF RESEARCH FINDINGS FOR VACCINE TRIALS: EXPERIENCES FROM TWO MALARIA VACCINE TRIALS INVOLVING HEALTHY CHILDREN ON THE KENYAN COAST
por: Gikonyo, Caroline, et al.
Publicado: (2013)

Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
por: Mtenga, Sally, et al.
Publicado: (2016)

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data
por: Nyandele, Jane Paula, et al.
Publicado: (2023)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data
por: Warimwe, George M, et al.
Publicado: (2013)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
por: Ndungu, Francis M., et al.
Publicado: (2012)

Assessment of parental perception of malaria vaccine in Tanzania
por: Romore, Idda, et al.
Publicado: (2015)

Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field
por: Olotu, Ally, et al.
Publicado: (2012)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
por: Abdulla, Salim, et al.
Publicado: (2013)

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010–2011
por: von Seidlein, Lorenz, et al.
Publicado: (2012)

Experience and challenges from clinical trials with malaria vaccines in Africa
por: Mwangoka, Grace, et al.
Publicado: (2013)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
por: Leach, Amanda, et al.
Publicado: (2011)

The case for ring vaccinations with special consideration of oral cholera vaccines
por: Deen, Jacqueline, et al.
Publicado: (2018)

Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01(E) in Young Children
por: Olotu, Ally, et al.
Publicado: (2014)

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
por: Romore, Idda, et al.
Publicado: (2016)

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
por: White, Michael T, et al.
Publicado: (2015)

The Relationship between RTS,S Vaccine-Induced Antibodies, CD4(+) T Cell Responses and Protection against Plasmodium falciparum Infection
por: White, Michael T., et al.
Publicado: (2013)

Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings
por: Mulamba, Charles, et al.
Publicado: (2022)

Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya
por: Olotu, Ally, et al.
Publicado: (2010)

Vaccines for Cholera Control: Does Herd Immunity Play a Role
por: von Seidlein, Lorenz
Publicado: (2007)

Correction: Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya
por: Olotu, Ally, et al.
Publicado: (2011)

The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa
por: Billingsley, Peter F., et al.
Publicado: (2020)

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
por: Ajua, Anthony, et al.
Publicado: (2015)

Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers
por: Tumbo, Anneth-Mwasi, et al.
Publicado: (2021)

Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya
por: Ibison, Frances, et al.
Publicado: (2012)

The Failure of Screening and Treating as a Malaria Elimination Strategy
por: von Seidlein, Lorenz
Publicado: (2014)

Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast
por: Kariuki, Symon M., et al.
Publicado: (2011)

Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya
por: Bejon, Philip, et al.
Publicado: (2010)

Correction: Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya
por: Bejon, Philip, et al.
Publicado: (2011)

Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine
por: Mwacharo, Jedidah, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_f8p10mr92umd0528hmqtd1isin